Azitra Inc Share Price
AZTRAzitra Inc Stock Performance
Open $0.20 | Prev. Close $0.21 | Circuit Range N/A |
Day Range $0.20 - $0.20 | Year Range $0.11 - $2.39 | Volume 601 |
Average Traded $0.20 |
Azitra Inc Share Price Chart
About Azitra Inc
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease. The company also develops ATR-04, a genetically modified strain of S. epidermidis that is in Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. It has a collaboration with Bayer. The company was incorporated in 2014 and is based in Branford, Connecticut.
Azitra Inc Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
05-Jun-26 | $0.21 | $0.21 | -2.31% |
04-Jun-26 | $0.22 | $0.22 | -1.82% |
03-Jun-26 | $0.22 | $0.22 | +2.80% |
02-Jun-26 | $0.21 | $0.21 | -4.46% |
01-Jun-26 | $0.23 | $0.22 | -1.75% |
29-May-26 | $0.22 | $0.23 | +9.62% |
28-May-26 | $0.21 | $0.21 | +0.97% |